ARGA Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.9M Sell
159,970
-45,093
-22% -$16.7M 1.58% 17
2026
Q1
$60M Sell
205,063
-72,692
-26% -$23.9M 1.97% 11
2025
Q4
$97.4M Buy
277,755
+12,285
+5% +$4.15M 2.65% 12
2025
Q3
$85.8M Buy
+265,470
New +$82.6M 2.27% 12
2017
Q2
Sell
-20,400
Closed -$3.37M 70
2017
Q1
$3.37M Sell
20,400
-2,900
-12% -$461K 0.48% 19
2016
Q4
$3.35M Sell
23,300
-9,300
-29% -$1.25M 0.75% 19
2016
Q3
$4.08M Hold
32,600
1.12% 11
2016
Q2
$4.28M Hold
32,600
1.34% 11
2016
Q1
$4.53M Buy
32,600
+15,200
+87% +$2.03M 1.5% 8
2015
Q4
$2.43M Buy
+17,400
New +$2.4M 0.81% 15
2013
Q3
Sell
-9,330
Closed -$763K 39
2013
Q2
$763K Buy
+9,330
New +$698K 0.28% 27

Other funds holding ELV

ARGA Investment Management's ELV Position: Q2 2026 in Review

ARGA Investment Management reduced its Elevance Health (ELV) stake by 22% in Q2 2026, selling an estimated $16.7M and leaving 159,970 shares worth $61.9M. The position accounts for 1.58% of the portfolio, ranked #17.

ARGA Investment Management first reported a position in ELV in Q2 2013 and has held it in 11 quarters since. The position peaked at $97.4M in Q4 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • ARGA Investment Management held 159,970 shares of Elevance Health worth $61.9M as of Q2 2026.
  • ARGA Investment Management sold 45,093 Elevance Health shares in Q2 2026, an estimated $16.7M.
  • Elevance Health made up 1.58% of ARGA Investment Management's portfolio in Q2 2026, its #17 holding.
  • ARGA Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 11 quarters since.
  • ARGA Investment Management's Elevance Health position peaked at $97.4M in Q4 2025.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on ARGA Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.